Contract manufacturing in the in-vitro diagnostics (IVD) allows IVD companies to focus on their core competencies, such as research and development, marketing, and sales, while leaving the manufacturing process to a specialized contract manufacturer. The contract manufacturing of IVD tests includes various stages, such as design, development, and production. Contract manufacturers work closely with IVD companies to ensure that the design and development of the test meet the required specifications. They also ensure that the test is produced in compliance with regulatory requirements. The global contract manufacturing in the in-vitro diagnostics (ivd) market is anticipated to increase by USD 5.7 billion till 2029 at an average annual growth of 8.4 percent as per the latest market estimates.
This industry report offers market estimates of the global market, followed by a detailed analysis of the practice area, and region. The global market data on contract manufacturing in the in-vitro diagnostics (ivd) can be segmented by practice area: assays and consumables, clinical development, full product development, research and development, testing and evaluation services. The research and development segment held the largest share of the global contract manufacturing in the in-vitro diagnostics (ivd) market in 2022 and is anticipated to hold its share during the forecast period. Contract manufacturing in the in-vitro diagnostics (ivd) market is further segmented by region: North America, Europe, Asia-Pacific, Rest of World (RoW). Globally, North America made up the largest share of the contract manufacturing in the in-vitro diagnostics (ivd) market.
The global contract manufacturing in the in-vitro diagnostics (ivd) market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Agilent Technologies Inc., Biokit S.A., Denka Seiken Co. Ltd., Flex Ltd., FUJIFILM Wako Pure Chemical Corporation, Fujirebio Inc, Merck Millipore Ltd, Meridian Life Science Inc, Plexus Corporation, Sekisui Diagnostics LLC, Tecan Group Ltd.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
▹ Get a detailed picture of the Global Contract Manufacturing in the In-vitro Diagnostics (IVD) Market
▹ Identify segments/areas to invest in over the forecast period in the Global Contract Manufacturing in the In-vitro Diagnostics (IVD) Market
▹ Understand the competitive environment, the market’s leading players
▹ The market estimate for ease of analysis across scenarios in Excel format.
▹ Strategy consulting and research support for three months.
▹ Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2022 |
| Forecast Year | 2023-2029 |
| CAGR (2023-2029) | 8.4% |
| Pages | 20 |
| Key Players | Agilent Technologies Inc., Biokit S.A., Denka Seiken Co. Ltd., Flex Ltd., FUJIFILM Wako Pure Chemical Corporation, Fujirebio Inc, Merck Millipore Ltd, Meridian Life Science Inc, Plexus Corporation, Sekisui Diagnostics LLC, Tecan Group Ltd. |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.
